UDXBIO 5 products have obtained EU CE certification

The new coronavirus rapid detection kit successfully developed by Henan UDX Biotechnology Co.,Ltd  is simple to operate, and the results can be interpreted by the naked eye in 15-20 minutes, which can provide rapid detection methods for suspected patients with new coronary pneumonia. This series of products has obtained CE certification, and can be sold and used in EU countries and countries that recognize the EU CE certification. It can meet the needs of clinical use, with stable performance, high sensitivity and specificity.

The new coronavirus antigen detection kit uses immune colloidal gold chromatography technology to qualitatively detect the new coronavirus (SARS-CoV-2) nucleocapsid protein antigen in human pharynx/nasopharyngeal swab specimens.

COVID-19 IGM/IGG ANTIBODIES introduction:

UDXBIO antibody detection kit uses immune colloidal gold chromatography technology to qualitatively detect the new coronavirus (SARS-CoV-2) IgM/IgG antibody in human serum, plasma, and whole blood samples in vitro.

The product can be conveniently and quickly used for early screening and early diagnosis of the virus infection in community health service centers, primary hospitals and families. It not only increases the timeliness of testing and diagnosis and treatment, but also can effectively prevent the masses from intensive inspections in large hospitals. cross infection.

Three New Products

Now Henan UDX Biotechnology Co.,Ltd has successfully developed and produced Influenza A+B Antigen Rapid Test (Influenza A/B Virus Antigen Rapid Test Kit), COVID-19 Antigen/Influenza A+B Antigen Combo Rapid Test (New Coronary, A and B Influenza) Virus antigen triple antigen rapid test kit), COVID-19 Antigen Rapid Test (saliva sample lollipop style), have obtained the EU CE certification, and can be sold and used in EU countries and countries that have recognized the EU CE certification.

Both the new coronavirus and influenza virus are respiratory viruses and can be spread through contact, droplets, etc. Studies have shown that factors such as dry and cold environments in winter and people often gathering in poorly ventilated rooms are conducive to the spread of these two viruses. The symptoms of the new coronavirus and influenza virus are also basically similar. Both have symptoms of fever, local body pain and chills, and both can cause pneumonia or severe lung infections. Its rapid detection and precise identification play an important role in epidemic prevention and control.

Influenza A+B Antigen Rapid Test can realize the rapid typing and detection of influenza A/B viruses through one-step operation. It plays a very important role in shortening the investigation time of influenza A cases, timely implementing prevention and control measures for influenza A, avoiding large-scale infection of influenza A, and reducing the occurrence of severe cases of influenza A.

While fighting the novel coronavirus pneumonia epidemic, we must be alert to the superimposed effects of seasonal influenza and the new crown. The COVID-19 Antigen/Influenza A+B Antigen Combo Rapid Test can realize the one-time detection and classification of the three viruses of new crown, influenza A, and influenza B. It is used for rapid triage of clinical and testing populations, and its rapid detection and precise identification effect on the epidemic Prevention and control play an important role.

COVID-19 Antigen Rapid Test (saliva sample lollipop style) is a non-invasive antigen saliva test for COVID-19. The lollipop-style test is especially suitable for children, the elderly and special groups. The operation is simpler and avoids swab sampling. Of discomfort.

All three rapid detection kits can be analyzed immediately at the sampling site, and the results can be observed with the naked eye in just 15-20 minutes. It is easy to use, does not require any equipment, and is especially suitable for large-scale on-site screening.

The kits developed and produced by UDXBio can meet the needs of clinical use, with stable performance, high sensitivity and specificity, and further help the prevention and control of pneumonia caused by new coronavirus infection and influenza on a global scale.